Sunlenca

Sunlenca (lenacapavir) is a prescription medication used to treat Multidrug-resistant HIV. A long-acting HIV medicine given as an injection just twice a year (with starter doses), used together with other antiretrovirals in adults with multidrug-resistant HIV.

A first-in-class capsid inhibitor that blocks the HIV protein shell at multiple stages of the virus's life cycle.

Commonly reported side effects of Sunlenca include Injection-site reactions, Nausea, Headache, and Risk of resistance if doses are missed. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Sunlenca has notable warnings and precautions. Tell your doctor about your medical history and any other medicines or supplements you take before starting Sunlenca.

The active ingredient in Sunlenca is lenacapavir, which belongs to a class of medicines known as Capsid Inhibitor.

Sunlenca is manufactured by Gilead Sciences. It was first approved in 2022.

You may be able to lower the cost of Sunlenca by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.